{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:45:52Z","timestamp":1648755952733},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>PURPOSE: To evaluate the development of Walker 256 tumor in male Wistar rats treated with tacrolimus using an experimental kidney tumor model. METHODS: 40 male Wistar rats were divided into four groups: Tumor group (TU) (n=10), Tacrolimus-Tumor group (TT) (n=10), Tacrolimus group (TC) (n=10) and Control group (C) (n=10). Treatment with tacrolimus was performed in groups TT and TC. Under anesthesia, the right kidney of each animal of TU and TT was accessed through a supraumbilical incision and inoculated with a 0.1mL solution containing 2x10(6) tumor cells (Walker 256 carcinosarcoma tumor cells). Group TC was treated with a saline solution. All the animals of groups TC and TT were treated with tacrolimus (5mg\/kg\/day) by gavage for 15 days. TU group animals received saline by gavage for 15 days. On the 15th postoperative day, all animals were submitted to euthanasia and blood sampling for analysis of serum creatinine (Cr) and blood urea nitrogen (BUN). Abdominal gross examination was performed, the right kidney removed and prepared for histological analysis by hematoxylin-eosin staining. The resulting data were submitted to statistical analysis by ANOVA. RESULTS: Statistical significance was found when comparing creatinine level between groups TU, TT and TC -TT group culminated with a marked increased in creatinine levels (Cr=1.013 \u00b1 0.3028 mg\/mL), TU group (Cr=0.5670 \u00b1 0.03536 mg\/dL) P=0.00256, TC group (Cr =0.711 \u00b1 0.1653 mg\/mL) P= 0.02832. Statistical significance was found when comparing BUN levels in TT group (71.32 \u00b1 17.14 mg\/mL), compared with TU group (45.83 \u00b1 5.046 mg\/dL), P=0.000318. There were no statistically significant differences between groups TT and TC (61.23 \u00b1 9.503 mg\/mL) P=0.7242. Histological analysis showed a poor evolution in TT group with multiple foci of hemorrhage and cortical invasion by the Walker tumor. CONCLUSION: The Tacrolimus-treated group developed a more aggressive tumor and a drug-related nephrotoxic effect.<\/jats:p>","DOI":"10.1590\/s0102-86502010000100020","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T09:47:17Z","timestamp":1264672037000},"page":"98-104","source":"Crossref","is-referenced-by-count":1,"title":["Action of tacrolimus on Wistar rat kidneys implanted with Walker 256 carcinosarcoma"],"prefix":"10.1590","volume":"25","author":[{"given":"Cristiano Machado","family":"In\u00e1cio","sequence":"first","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich Andr\u00e9as","family":"Dietz","sequence":"additional","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo","family":"Malafaia","sequence":"additional","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurandir Marcondes","family":"Ribas Filho","sequence":"additional","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Afonso Nunes","family":"Nassif","sequence":"additional","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolau Gregori","family":"Czeczko","sequence":"additional","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Australia Paredes","family":"Marcondes","sequence":"additional","affiliation":[{"name":"University Evangelic Hospital,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/gfm085","article-title":"Malignancies in kidney transplantation: an unmet medical need","volume":"22","author":"Dantal J","year":"2007","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"ref2","first-page":"161","article-title":"Tumores malignos no p\u00f3s-transplante renal","volume":"21","author":"Ianhez LE","year":"1999","journal-title":"J Bras Nefrol."},{"key":"ref3","first-page":"7","article-title":"Morbidade e mortalidade em transplante renal no Brasil","volume":"29","author":"Mazzali M","year":"2004","journal-title":"Int Braz J Urol."},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.transproceed.2004.03.057","article-title":"Mycophenolate mofetil attenuates Walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine","volume":"36","author":"Silva SL","year":"2004","journal-title":"Transplant Proc."},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/S0102-86502004000400011","article-title":"Modelo experimental de tumor na cavidade oral de ratos com carcinossarcoma de Walker 256","volume":"19","author":"Alves APNN","year":"2004","journal-title":"Acta Cir Bras."},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/S0102-86502002000100009","article-title":"Modelo de tumor experimental em rim de ratos","volume":"17","author":"Silva LFG","year":"2002","journal-title":"Acta Cir Bras."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/S0004-27302003000300007","article-title":"Transplante simult\u00e2neo de p\u00e2ncreas-rim em portador de Diabetes Mellitus tipo 1 com insufici\u00eancia renal cr\u00f4nica: Experi\u00eancia inicial do Hospital Angelina Caron","volume":"3","author":"Nicoluzzi JE","year":"2003","journal-title":"Arq Bras Endocrinol Metab."},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.ftd.0000146874.11480.8a","article-title":"Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function","volume":"27","author":"Barten MJ","year":"2005","journal-title":"Ther Drug Monit."},{"issue":"1","key":"ref9","first-page":"822","article-title":"Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring","volume":"27","author":"Winkler M","year":"1995","journal-title":"Transplant Proc."},{"key":"ref10","first-page":"301","article-title":"Pathology of tumours in laboratory animals: Tumours of the rat. Tumours of the kidney, kidney pelvis and ureter","volume":"99","author":"Hard GC","year":"1990","journal-title":"IARC Sci Publ."},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0041-1345(98)00448-5","article-title":"Impact of sandimmune, neoral, and prograf on rejection incidence and renal function in primary liver transplant recipients","volume":"30","author":"Van Buren D","year":"1998","journal-title":"Transplant Proc."},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00007890-199401000-00009","article-title":"Evaluation of cyclosporine, mycophenolate mofetil, and Brequinar sodium combination therapy on hamster-to-rat cardiac xenotransplantation","volume":"57","author":"Fujino Y","year":"1994","journal-title":"Transplantation","ISSN":"http:\/\/id.crossref.org\/issn\/0041-1337","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in kidney transplantation: meta-analysis of randomised trials","volume":"318","author":"Greg A","year":"1999","journal-title":"BMJ."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.TP.0000126926.61434.A5","article-title":"Tacrolimus and transplantation: a decade in review","volume":"77","author":"Fung JJ","year":"2004","journal-title":"Transplantation."},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","article-title":"Mechanisms of clinically relevant drug interactions associated with tacrolimus","volume":"41","author":"Christians U","year":"2002","journal-title":"Clin Pharmacokinet."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/gfm084","article-title":"The role of proliferation signal inhibitors in post-transplant malignancies","volume":"22","author":"Gutierrez-Dalmau A","year":"2007","journal-title":"Nephrol Dial Transplant."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske BL","year":"2004","journal-title":"Am J Transplant."},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.TP.0000081399.75231.3B","article-title":"Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression","volume":"76","author":"Maluccio M","year":"2003","journal-title":"Source Transplant."},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jso.2930020312","article-title":"Facilitated metastatic distribution of the Walker 256 tumor in sprague-dawley rats with hydrocortisone and\/or cyclophosphamide","volume":"2","author":"Everett V","year":"1970","journal-title":"J Surg Oncol."},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejim.2006.04.014","article-title":"Pleural dissemination of thymoma showing tumor regression after combined corticosteroid and tacrolimus therapy","volume":"17","author":"Taguchi T","year":"2006","journal-title":"Eur J Intern Med."},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2133.2003.05735.x","article-title":"Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin","volume":"149","author":"Niwa Y","year":"2003","journal-title":"Br J Dermatol."},{"issue":"6","key":"ref22","first-page":"3197","article-title":"Effect of FK 506 on experimental liver carcinogenesis","volume":"23","author":"Shinozuka H","year":"1991","journal-title":"Transplant Proc."},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1081\/JDI-100101963","article-title":"Re-assessment of kidney hydrossaline disfunction in rats bearing Walker-256 tumor","volume":"22","author":"Rettori O","year":"2000","journal-title":"Ren Fail."}],"container-title":["Acta Cirurgica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/acb\/v25n1\/20.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T14:27:41Z","timestamp":1495808861000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502010000100020&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0102-86502010000100020"],"URL":"https:\/\/doi.org\/10.1590\/s0102-86502010000100020","relation":{},"ISSN":["0102-8650"],"issn-type":[{"value":"0102-8650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}